Skip to content
Screener

Solventum SOLV Q4 2025 Annual earnings

Reported February 26, 2026 · After market close

Revenue$2.0BBeat by $36.1M
EPS$1.57Beat by $0.07
Revenue estimate$2.0B
EPS estimate$1.50

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.9B
EPS estimate$1.35

Financials

Q4 2025

Income statement

See full
Revenue$2.0B-3.7%
Gross profit$1.0B-8.2%
Operating income$124.0M-8.8%
Net income$63.0M+103%
EPS (diluted)$0.35+94.4%

Balance sheet

See full
Cash & equivalents$878.0M+15.2%
Total debt$5.2B-35.9%
Total equity$5.0B+70.6%
Total assets$14.3B-1.1%

Cash flow

See full
Operating cash flow$95.0M-56.6%
CapEx$63.0M-50.4%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$13.74B+20.4%
Enterprise value$18.11B-3.8%
P/E8.8×-15.0×
P/S1.7×+0.3×

Profitability

See full
Gross margin53.5%-2.2pp
Operating margin26.2%+13.6pp
Net margin18.7%+12.9pp

Returns & leverage

See full
Return on equity38.9%+32.3pp
Debt / equity1×-1.7×
Current ratio1.2×0.0×

Segments

By segment

See full
MedSurg$1.2B+5.3%
Health Information Systems$348.0M+3.9%
Dental Solutions$343.0M+8.5%
Purification and Filtration Segment--100%

By product

See full
Cost of software and rentals$508.0M+3.0%

FAQ

When did Solventum report Q4 2025 earnings?
Solventum (SOLV) reported Q4 2025 earnings on February 26, 2026 after market close.
What were Solventum's Q4 2025 revenue and EPS?
Solventum reported revenue of $2.0B and eps of $1.57 for Q4 2025.
Did Solventum beat estimates in Q4 2025?
Revenue beat the consensus estimate of $2.0B by $36.1M. EPS beat the consensus estimate of $1.50 by $0.07.
How did Solventum's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.7% from $2.1B a year earlier and eps grew 11.3% from $1.41.
Where can I find Solventum's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001964738-26-000005) and the 10-K periodic report (0001964738-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.